Cyanine-related Compounds: a Novel Class of Potent Inhibitors of Extraneuronal Noradrenaline Transport

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1993 Nov 1

PMID 8114944

Citations 16

Authors

H Russ

J Sonna

K Keppler

S Baunach

E Schomig

Affiliations

Soon will be listed here.

Abstract

The neurotransmitter noradrenaline is removed from the extracellular space by neuronal and extraneuronal transport mechanisms. In the past, further functional and biochemical characterisation of the corticosterone-sensitive extraneuronal transporter was hampered by the lack of highly potent inhibitors. Here we describe a new class of selective and highly potent inhibitors of the extraneuronal noradrenaline transporter. Clonal Caki-1 cells possess the human type of extraneuronal noradrenaline carrier. The effect of various steroids and steroid-like compounds on initial rates of specific 3H-noradrenaline transport in Caki-1 cells was investigated. None of these steroids had an inhibitory potency higher than that of corticosterone which hitherto was generally accepted as the most potent inhibitor of the extraneuronal noradrenaline transport. On the other hand, a variety of quinoline and isoquinoline derivatives interacted with the extraneuronal noradrenaline transporter. Several cationic quinolines that belong to the chemical class of the cyanine dyes turned out to be very potent inhibitors of 3H-noradrenaline transport in Caki-1 cells. The isocyanines, 1,1'-diisopropyl-2,4'-cyanine (disprocynium24) and 1-methyl-1'-isopropyl-2,4'-cyanine as well as the pseudoisocyanines 1,1'-diethyl-2,2'-cyanine (decynium22) and 1-isopropyl-1'-ethyl-2,2'-cyanine (iprecynium22) were most potent with IC50's of 14, 62, 16, and 18 nmol/l, respectively. The inhibitory potency on extraneuronal noradrenaline transport of 1-methyl-1'-isopropyl-2,4'-cyanine was determined also in isolated organs, namely the isolated incubated rabbit aorta and the isolated perfused rat heart.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Substrates and Inhibitors of Organic Cation Transporters (OCTs) and Plasma Membrane Monoamine Transporter (PMAT) and Therapeutic Implications.

Bonisch H Handb Exp Pharmacol. 2021; 266:119-167.

PMID: 34495395 DOI: 10.1007/164_2021_516.

Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter.

Fraser-Spears R, Krause-Heuer A, Basiouny M, Mayer F, Manishimwe R, Wyatt N Eur J Pharmacol. 2018; 842:351-364.

PMID: 30473490 PMC: 6440482. DOI: 10.1016/j.ejphar.2018.10.028.

Lipophilic Cationic Cyanines Are Potent Complex I Inhibitors and Specific in Vitro Dopaminergic Toxins with Mechanistic Similarities to Both Rotenone and MPP(.).

Kadigamuwa C, Mapa M, Wimalasena K Chem Res Toxicol. 2016; 29(9):1468-79.

PMID: 27510327 PMC: 6245648. DOI: 10.1021/acs.chemrestox.6b00138.

2, 2'- and 4, 4'-Cyanines are transporter-independent in vitro dopaminergic toxins with the specificity and mechanism of toxicity similar to MPP⁺.

Kadigamuwa C, Le V, Wimalasena K J Neurochem. 2015; 135(4):755-67.

PMID: 26094622 PMC: 4793973. DOI: 10.1111/jnc.13201.

Membrane potential and pH-dependent accumulation of decynium-22 (1,1'-diethyl-2,2'-cyanine iodide) flourencence through OCT transporters in astrocytes.

Inyushin M, Kucheryaykh Y, Kucheryavykh L, Sanabria P, Jimenez-Rivera C, Struganova I Bol Asoc Med P R. 2013; 102(3):5-12.

PMID: 23875515 PMC: 3721433.

References

Salt P . Inhibition of noradrenaline uptake 2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines. Eur J Pharmacol. 1972; 20(3):329-40. DOI: 10.1016/0014-2999(72)90194-x. View

de la Lande I, Marino V, Lavranos T, Kennedy J, Parker D, Seamark R . Distribution of extraneuronal uptake1 in reproductive tissues: studies on cells in culture. J Neural Transm Suppl. 1991; 34:37-42. DOI: 10.1007/978-3-7091-9175-0_5. View

Harder R, Bonisch H . Large-scale preparation of plasma membrane vesicles from PC-12 pheochromocytoma cells and their use in noradrenaline transport studies. Biochim Biophys Acta. 1984; 775(1):95-104. DOI: 10.1016/0005-2736(84)90239-6. View

Uhl G, Hartig P . Transporter explosion: update on uptake. Trends Pharmacol Sci. 1992; 13(12):421-5. DOI: 10.1016/0165-6147(92)90133-q. View

Henseling M . Kinetic constants for uptake and metabolism of 3H-(-)noradrenaline in rabbit aorta. Possible falsification of the constants by diffusion barriers within the vessel wall. Naunyn Schmiedebergs Arch Pharmacol. 1983; 323(1):12-23. DOI: 10.1007/BF00498822. View

Schomig E, Azevedo I, Moura D, Trendelenburg U . The influence of the density of adrenergic innervation on the extracellular steady-state concentration gradient for 3H-noradrenaline. Naunyn Schmiedebergs Arch Pharmacol. 1992; 345(5):541-3. DOI: 10.1007/BF00168945. View

Schomig E, Korber M, Bonisch H . Kinetic evidence for a common binding site for substrates and inhibitors of the neuronal noradrenaline carrier. Naunyn Schmiedebergs Arch Pharmacol. 1988; 337(6):626-32. DOI: 10.1007/BF00175787. View

Iversen L . The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: A novel catechol amine uptake process. Br J Pharmacol Chemother. 2008; 25(1):18-33. PMC: 1510677. DOI: 10.1111/j.1476-5381.1965.tb01753.x. View

Graham D, Langer S . Advances in sodium-ion coupled biogenic amine transporters. Life Sci. 1992; 51(9):631-45. DOI: 10.1016/0024-3205(92)90236-i. View

10.

Kishino J, Hanasaki K, Nagasaki T, Arita H . Kinetic studies on stereospecific recognition by the thromboxane A2/prostaglandin H2 receptor of the antagonist, S-145. Br J Pharmacol. 1991; 103(4):1883-8. PMC: 1908203. DOI: 10.1111/j.1476-5381.1991.tb12346.x. View

11.

Iversen L, Salt P . Inhibition of catecholamine Uptake-2 by steroids in the isolated rat heart. Br J Pharmacol. 1970; 40(3):528-30. PMC: 1703119. DOI: 10.1111/j.1476-5381.1970.tb10637.x. View

12.

Schomig E, Babin-Ebell J, Russ H . 1,1'-diethyl-2,2'-cyanine (decynium22) potently inhibits the renal transport of organic cations. Naunyn Schmiedebergs Arch Pharmacol. 1993; 347(4):379-83. DOI: 10.1007/BF00165387. View

13.

Pacholczyk T, Blakely R, Amara S . Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature. 1991; 350(6316):350-4. DOI: 10.1038/350350a0. View

14.

Russ H, Gliese M, Sonna J, Schomig E . The extraneuronal transport mechanism for noradrenaline (uptake2) avidly transports 1-methyl-4-phenylpyridinium (MPP+). Naunyn Schmiedebergs Arch Pharmacol. 1992; 346(2):158-65. DOI: 10.1007/BF00165297. View

15.

Green A . The kinetics of enzyme action and inhibition in intact tissues and tissue slices, with special reference to cholinesterase. J Pharm Pharmacol. 1976; 28(4):265-74. DOI: 10.1111/j.2042-7158.1976.tb04151.x. View

16.

Bonisch H, Trendelenburg U . Extraneuronal removal, accumulation and O-methylation of isoprenaline in the perfused heart. Naunyn Schmiedebergs Arch Pharmacol. 1974; 283(2):191-218. DOI: 10.1007/BF00501145. View

17.

Hollister L . Tricyclic antidepressants (first of two parts). N Engl J Med. 1978; 299(20):1106-9. DOI: 10.1056/NEJM197811162992004. View

18.

Lee C, Javitch J, Snyder S . Recognition sites for norepinephrine uptake: regulation by neurotransmitter. Science. 1983; 220(4597):626-9. DOI: 10.1126/science.6301013. View

19.

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

20.

Schomig E, Schonfeld C . Extraneuronal noradrenaline transport (uptake2) in a human cell line (Caki-1 cells). Naunyn Schmiedebergs Arch Pharmacol. 1990; 341(5):404-10. DOI: 10.1007/BF00176331. View